• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用[镓]镓-PSMA-11 PET/CT评估影像组学和临床特征在转移性前列腺癌中的预后价值。

Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [Ga]Ga-PSMA-11 PET/CT.

作者信息

Molin Kaylee, Barry Nathaniel, Gill Suki, Hassan Ghulam Mubashar, Francis Roslyn J, Ong Jeremy S L, Ebert Martin A, Kendrick Jake

机构信息

School of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.

Centre for Advanced Technologies in Cancer Research (CATCR), Perth, WA, Australia.

出版信息

Phys Eng Sci Med. 2025 Mar;48(1):329-341. doi: 10.1007/s13246-024-01516-8. Epub 2025 Jan 9.

DOI:10.1007/s13246-024-01516-8
PMID:39786674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11996952/
Abstract

Prostate cancer is a significant global health issue due to its high incidence and poor outcomes in metastatic disease. This study aims to develop models predicting overall survival for patients with metastatic biochemically recurrent prostate cancer, potentially helping to identify high-risk patients and enabling more tailored treatment options. A multi-centre cohort of 180 such patients underwent [Ga]Ga-PSMA-11 PET/CT scans, with lesions semi-automatically segmented and radiomic features extracted from lesions. The analysis included two phases: univariable and multivariable. Univariable analysis used Kaplan-Meier curves and Cox proportional hazards models to correlate individual features with overall survival. Multivariable analysis used the LASSO Cox proportional hazards method to create 13 models: radiomics-only, clinical-only, and various combinations of radiomic and clinical features. Each model included six features and was bootstrapped 1000 times to obtain concordance indices with 95% confidence intervals, followed by optimism correction. In the univariable analysis, 6 out of 8 clinical features and 68 out of 89 radiomic features were significantly correlated with overall survival, including age, disease stage, total lesional uptake and total lesional volume. The optimism-corrected concordance indices from the multivariable models were 0.722 (95% CI 0.653-0.784) for the clinical model, 0.681 (95% CI 0.616-0.745) for the radiomics model, and 0.704 (95% CI 0.648-0.768) for the combined model with three clinical and three radiomic features, when extracting radiomic features from the largest lesion only. While univariable analysis showed significant prognostic value for many radiomic features, their integration into multivariable models did not improve predictive accuracy beyond clinical features alone.

摘要

前列腺癌因其高发病率和转移性疾病的不良预后,成为一个重大的全球健康问题。本研究旨在开发预测转移性生化复发前列腺癌患者总生存期的模型,这可能有助于识别高危患者,并提供更具针对性的治疗方案。一个由180名此类患者组成的多中心队列接受了[镓]镓-PSMA-11 PET/CT扫描,对病变进行半自动分割,并从病变中提取影像组学特征。分析包括两个阶段:单变量分析和多变量分析。单变量分析使用Kaplan-Meier曲线和Cox比例风险模型将个体特征与总生存期相关联。多变量分析使用LASSO Cox比例风险方法创建13个模型:仅影像组学模型、仅临床模型以及影像组学和临床特征的各种组合。每个模型包含六个特征,并进行1000次自助抽样以获得具有95%置信区间的一致性指数,随后进行乐观校正。在单变量分析中,8个临床特征中的6个以及89个影像组学特征中的68个与总生存期显著相关,包括年龄、疾病分期、总病变摄取和总病变体积。当仅从最大病变中提取影像组学特征时,多变量模型经乐观校正后的一致性指数分别为:临床模型0.722(95%CI 0.653 - 0.784),影像组学模型0.681(95%CI 0.616 - 0.745),以及具有三个临床和三个影像组学特征的联合模型0.704(95%CI 0.648 - 0.768)。虽然单变量分析显示许多影像组学特征具有显著的预后价值,但将它们整合到多变量模型中并未比单独的临床特征提高预测准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/ebbde3d8fe39/13246_2024_1516_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/9d30e00d8dde/13246_2024_1516_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/04b6cd50be2d/13246_2024_1516_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/536421c52197/13246_2024_1516_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/93c27f2642d3/13246_2024_1516_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/ebbde3d8fe39/13246_2024_1516_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/9d30e00d8dde/13246_2024_1516_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/04b6cd50be2d/13246_2024_1516_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/536421c52197/13246_2024_1516_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/93c27f2642d3/13246_2024_1516_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a69/11996952/ebbde3d8fe39/13246_2024_1516_Fig5_HTML.jpg

相似文献

1
Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [Ga]Ga-PSMA-11 PET/CT.使用[镓]镓-PSMA-11 PET/CT评估影像组学和临床特征在转移性前列腺癌中的预后价值。
Phys Eng Sci Med. 2025 Mar;48(1):329-341. doi: 10.1007/s13246-024-01516-8. Epub 2025 Jan 9.
2
Machine learning-based analysis of Ga-PSMA-11 PET/CT images for estimation of prostate tumor grade.基于机器学习的 Ga-PSMA-11 PET/CT 图像分析用于估计前列腺肿瘤分级。
Phys Eng Sci Med. 2024 Jun;47(2):741-753. doi: 10.1007/s13246-024-01402-3. Epub 2024 Mar 25.
3
Assessing the Heterogeneity of Response of [Ga] Ga-PSMA-11 PET/CT Lesions in Patients With Biochemical Recurrence of Prostate Cancer.评估前列腺癌生化复发患者中 [Ga]Ga-PSMA-11 PET/CT 病灶反应的异质性。
Clin Genitourin Cancer. 2024 Oct;22(5):102155. doi: 10.1016/j.clgc.2024.102155. Epub 2024 Jul 6.
4
[Ga]Ga‑PSMA‑617 PET-based radiomics model to identify candidates for active surveillance amongst patients with GGG 1-2 prostate cancer at biopsy.基于[Ga]Ga‑PSMA‑617 PET 的放射组学模型,用于在活检时识别 GGG 1-2 前列腺癌患者中适合主动监测的候选者。
Cancer Imaging. 2024 Jul 4;24(1):86. doi: 10.1186/s40644-024-00735-2.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
[Clinical Value of Dual Tracer PET Imaging With Ga-PSMA and F-FDG in Patients With Metastatic Prostate Cancer].[镓-前列腺特异性膜抗原(Ga-PSMA)与氟代脱氧葡萄糖(F-FDG)双示踪剂PET成像在转移性前列腺癌患者中的临床价值]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Sep 20;55(5):1063-1070. doi: 10.12182/20240960201.
7
Prospective inter- and intra-tracer repeatability analysis of radiomics features in [Ga]Ga-PSMA-11 and [F]F-PSMA-1007 PET scans in metastatic prostate cancer.[Ga]Ga-PSMA-11 和 [F]F-PSMA-1007 PET 扫描在转移性前列腺癌中进行放射组学特征的前瞻性内和内示踪剂重复性分析。
Br J Radiol. 2023 Dec;96(1152):20221178. doi: 10.1259/bjr.20221178. Epub 2023 Oct 24.
8
Machine learning models for enhanced diagnosis and risk assessment of prostate cancer with Ga-PSMA-617 PET/CT.用于通过镓-PSMA-617正电子发射断层扫描/计算机断层扫描(Ga-PSMA-617 PET/CT)增强前列腺癌诊断和风险评估的机器学习模型。
Eur J Radiol. 2025 May;186:112063. doi: 10.1016/j.ejrad.2025.112063. Epub 2025 Mar 19.
9
Total-Body Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines.全身 Ga-PSMA-11 PET/CT 检测前列腺癌患者骨转移:对骨扫描指南的潜在影响。
J Nucl Med. 2020 Mar;61(3):405-411. doi: 10.2967/jnumed.119.230318. Epub 2019 Sep 20.
10
Evaluation of the prostate cancer and its metastases in the [ 68 Ga]Ga-PSMA PET/CT images: deep learning method vs. conventional PET/CT processing.[68Ga]Ga-PSMA PET/CT 图像中前列腺癌及其转移灶的评估:深度学习方法与传统 PET/CT 处理方法的比较。
Nucl Med Commun. 2024 Nov 1;45(11):974-983. doi: 10.1097/MNM.0000000000001891. Epub 2024 Sep 3.

本文引用的文献

1
Multicentric Ga-PSMA PET radiomics for treatment response assessment of Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.多中心Ga-PSMA PET放射组学用于评估转移性去势抵抗性前列腺癌患者接受Lu-PSMA-617放射性配体治疗的疗效
Front Nucl Med. 2023 Sep 14;3:1234853. doi: 10.3389/fnume.2023.1234853. eCollection 2023.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Prognostic Value of F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
基于 F-FDG PET 影像组学特征的弥漫性大 B 细胞淋巴瘤 PET 引导巩固治疗策略的预后价值:来自 GAINED 研究的机器学习分析。
J Nucl Med. 2024 Jan 2;65(1):156-162. doi: 10.2967/jnumed.123.265872.
4
Prospective inter- and intra-tracer repeatability analysis of radiomics features in [Ga]Ga-PSMA-11 and [F]F-PSMA-1007 PET scans in metastatic prostate cancer.[Ga]Ga-PSMA-11 和 [F]F-PSMA-1007 PET 扫描在转移性前列腺癌中进行放射组学特征的前瞻性内和内示踪剂重复性分析。
Br J Radiol. 2023 Dec;96(1152):20221178. doi: 10.1259/bjr.20221178. Epub 2023 Oct 24.
5
Role of radiomic analysis of [F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging.[F]氟甲基胆碱 PET/CT 影像组学分析在预测初诊中高危前列腺癌患者生化复发中的作用。
Eur Radiol. 2023 Oct;33(10):7199-7208. doi: 10.1007/s00330-023-09642-9. Epub 2023 Apr 20.
6
A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes.基于 PSMA PET 衍生的器官特异性肿瘤体积的前列腺癌预后风险评分。
Radiology. 2023 May;307(4):e222010. doi: 10.1148/radiol.222010. Epub 2023 Apr 18.
7
Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [Ga]Ga-PSMA-11 PET/CT images.从全身[Ga]Ga-PSMA-11 PET/CT 图像中转移性前列腺病变分割中全自动提取预后生物标志物。
Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):67-79. doi: 10.1007/s00259-022-05927-1. Epub 2022 Aug 17.
8
Images Are Data: Challenges and Opportunities in the Clinical Translation of Radiomics.图像即数据:影像组学临床转化面临的挑战与机遇
Cancer Res. 2022 Jun 6;82(11):2066-2068. doi: 10.1158/0008-5472.CAN-22-1183.
9
Best Approaches and Updates for Prostate Cancer Biochemical Recurrence.前列腺癌生化复发的最佳方法和更新。
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-8. doi: 10.1200/EDBK_351033.
10
Predicting cancer outcomes with radiomics and artificial intelligence in radiology.利用放射组学和人工智能技术预测癌症预后。
Nat Rev Clin Oncol. 2022 Feb;19(2):132-146. doi: 10.1038/s41571-021-00560-7. Epub 2021 Oct 18.